XML 49 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 6 - Disclosures to the interim condensed consolidated statements of income or loss - Planned Volume Of The Program, Weighted Average Fair Value, Total Expense And Corresponding Increase In Equity (Details) - EUR (€)
€ / shares in Units, € in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Weighted average fair value at reporting date (EUR) € 2.83 € 2.83
Increase in equity (kEUR) € 1,221 € 1,165
Proportionate fair value of ESOP recognized in other general and administrative expense 61  
Proportionate fair value of ESOP recognized in selling and distribution expense 20  
Proportionate fair value of ESOP recognized in cost of research and development € 211  
Employee Stock Option Program or ESOP    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Number of options planned to be granted 506,379  
Weighted average fair value at reporting date (EUR) € 2.77  
Expense of the period (kEUR) € 292,264  
Increase in equity (kEUR) € 292,264